I n a recent SEC filing, MiNK Therapeutics, Inc., a biopharmaceutical company, declared the implementation of a reverse stock split of its common stock. The decision was made official following a ...

Each Finder’s Warrant shall entitle the holder thereof to acquire one (1) common share of the Company for a period of thirty-six (36) months from the date of issuance at an exercise price of $0.20.

Each Finder's Warrant shall entitle the holder thereof to acquire one (1) common share of the Company for a period of thirty-six (36) months from the date of issuance at an exercise price of $0.20.

TORONTO, March 13, 2025 (GLOBE NEWSWIRE) — Mink Ventures Corporation (TSXV ... Each HD Unit will consist of one common share of the Company (a “Common Share”) and one Common Share purchase ...

“We believe MiNK Therapeutics is on solid footing to pioneer the next generation of cell therapies,” added Dr. Buell. “We will continue to pair scientific discipline with operational rigor, a strategy ...

To complete the exercise of the Option, Mink today issued the final tranche of 750,000 common shares of Mink to US Copper Corp. In addition, Mink has expended the required $300,000 in exploration ...